AstraZeneca halts nerve growth drug study
London, December 28, 2010
British drugmaker AstraZeneca has halted studies on Medi-578, which treats nerve growth, to assess data on the product further.
'We saw a reason to put a halt to the studies to evaluate the data and ascertain a sensible path forward,' an AstraZeneca spokeswoman said on Tuesday.
Several leading drug companies around the world have suffered setbacks in plans to develop new products.
Earlier this month, AstraZeneca discontinued development of experimental drug motavizumab and abandoned plans to develop an experimental heart drug known as Certriad along with its American partner Abbott Laboratories.
Earlier this week, Regeneron Pharmaceuticals said US regulators had placed the company's experimental pain drug for osteoarthritis on clinical hold after a patient in another company's trial developed a serious bone disorder.
Regeneron said it and partner Sanofi-Aventis SA were told late last week by the US Food and Drug Administration that the drug, Regn475/SAR164877, was being placed on clinical hold after a patient in another company's trial developed avascular necrosis of a joint.-Reuters
More Health & Environment Stories
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference